BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2650214)

  • 1. The benefits of HLA matching on renal transplantation relative to cyclosporine use and organ sharing.
    Sanfilippo F; Vaughn WK; LeFor WM; Alexander JW; Pfaff WW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):661-2. PubMed ID: 2650214
    [No Abstract]   [Full Text] [Related]  

  • 2. Organ sharing for good HLA-A,B, and DR matching improves cadaver renal graft survival in SEOPF: retrospective and prospective studies considering delayed graft function, race, center effects, cyclosporine, and other factors.
    Sanfilippo F; Vaughn WK; Alexander JW; LeFor WM; Lucas BA; Pfaff WW
    Clin Transpl; 1988; ():211-23. PubMed ID: 3154474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cadaveric renal transplantation after pulsatile perfusion, histocompatibility matching, and conversion to cyclosporine therapy.
    Milgrom M; Kyriakides GK; Esquenazi V; Olson L; Miller J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1873. PubMed ID: 3274444
    [No Abstract]   [Full Text] [Related]  

  • 4. In defense of organ sharing in kidney transplantation.
    Bradley BA; Gilks WR; Gore SM; Klouda PT; Selwood NH; Ray TC
    Clin Transpl; 1987; ():261-7. PubMed ID: 3154414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988.
    Persijn GG; D'Amaro J; De Lange P; Schreuder GM; Thorogood J; Zantvoort F; Van Rood JJ
    Clin Transpl; 1988; ():237-48. PubMed ID: 3154476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression.
    Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D
    Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients.
    Opelz G; Schwarz V; Engelmann A; Back D; Wilk M; Keppel E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):373-5. PubMed ID: 1990556
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA matching for cadaver renal transplantation in SEOPF: the impact of cyclosporine. Southeastern Organ Procurement Foundation.
    Sanfilippo F; Vaughn WK; Lefor WM
    Clin Transpl; 1986; ():109-20. PubMed ID: 3154372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of shared kidneys.
    Takiff H
    Clin Transpl; 1987; ():317-24. PubMed ID: 3154425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine A, hyperimmunized patients, and renal retransplantation.
    Hendriks GF; de Lange P; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):733-4. PubMed ID: 3274857
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of HLA matching in 10,000 cyclosporine-treated cadaver kidney transplants.
    Opelz G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):641-6. PubMed ID: 3547834
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of purposeful sharing by HLA matching in the South Eastern Organ Procurement Foundation (SEOPF).
    Pfaff WW; Sanfilippo F; Lucas BA; Vaughn WK
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1405-7. PubMed ID: 2652453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HLA matching supersedes many others for long-term cadaver kidney transplants.
    Milgrom M; Gomez C; Esquenazi V; Olson L; Roth D; Miller J
    Transplant Proc; 1989 Feb; 21(1 Pt 1):675-6. PubMed ID: 2650218
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of DR and DR6 matching on cadaver kidney transplant survival.
    Reyman TA; Toledo-Pereyra LH
    Transplant Proc; 1987 Feb; 19(1 Pt 1):702-4. PubMed ID: 3274848
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue typing in renal transplantation: the impact of cyclosporine.
    Benvenisty AI; Cohen DJ; Hardy MA
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):19-28. PubMed ID: 2938321
    [No Abstract]   [Full Text] [Related]  

  • 16. The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection.
    Levey AS
    Arch Intern Med; 1984 Dec; 144(12):2382-7. PubMed ID: 6391406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The results of renal transplantation with cyclosporine in immunologically high-risk patients.
    Dickerman RM; Vergne-Marini P; Langley J; Trevino G; Velez R; Brinker K; Nesser D; Long D; Hull AR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1846-8. PubMed ID: 3079047
    [No Abstract]   [Full Text] [Related]  

  • 18. Beneficial HLA matching in centers using cyclosporine A.
    Bradley BA; Gilks W; Gore SM; Klouda PT; Selwood NH
    Clin Transpl; 1986; ():93-8. PubMed ID: 3154457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine A and histocompatibility in kidney transplantation.
    Cook DJ; Terasaki PI
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):244-8. PubMed ID: 3291250
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with 130 consecutive renal transplants in the Middle East with special reference to histocompatibility matching, antirejection therapy with antilymphocyte globulin (ALG), and prolonged preservation of imported cadaveric grafts.
    Abouna GM; Kumar MS; White AG; Daddah S; John P; Samhan M; Omar OF; Kusma G
    Transplant Proc; 1984 Aug; 16(4):1114-7. PubMed ID: 6380057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.